These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25579084)

  • 1. Organization for rare diseases India (ORDI) - addressing the challenges and opportunities for the Indian rare diseases' community.
    Rajasimha HK; Shirol PB; Ramamoorthy P; Hegde M; Barde S; Chandru V; Ravinandan ME; Ramchandran R; Haldar K; Lin JC; Babar IA; Girisha KM; Srinivasan S; Navaneetham D; Battu R; Devarakonda R; Kini U; Vijayachandra K; Verma IC
    Genet Res (Camb); 2014 Aug; 96():e009. PubMed ID: 25579084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridging the Gap between Health and Social Care for Rare Diseases: Key Issues and Innovative Solutions.
    Castro R; Senecat J; de Chalendar M; Vajda I; Dan D; Boncz B;
    Adv Exp Med Biol; 2017; 1031():605-627. PubMed ID: 29214594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of 11 national policies for rare diseases in the context of key patient needs.
    Dharssi S; Wong-Rieger D; Harold M; Terry S
    Orphanet J Rare Dis; 2017 Mar; 12(1):63. PubMed ID: 28359278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of rare disease patients from a grassroot perspective: the role of patients' organizations in the global recognition of rare diseases in Cameroon.
    Ngoumou RD; Feudjio YBD
    Pan Afr Med J; 2024; 47():64. PubMed ID: 38681114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global health for rare diseases through primary care.
    Baynam G; Hartman AL; Letinturier MCV; Bolz-Johnson M; Carrion P; Grady AC; Dong X; Dooms M; Dreyer L; Graessner H; Granados A; Groza T; Houwink E; Jamuar SS; Vasquez-Loarte T; Tumiene B; Wiafe SA; Bjornson-Pennell H; Groft S
    Lancet Glob Health; 2024 Jul; 12(7):e1192-e1199. PubMed ID: 38876765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data.
    Groft SC; Posada de la Paz M
    Adv Exp Med Biol; 2017; 1031():3-21. PubMed ID: 29214563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not Available].
    Med Sci (Paris); 2016 Apr; 32 Spec No 1():8-11. PubMed ID: 27137854
    [No Abstract]   [Full Text] [Related]  

  • 8. Rare diseases - avoiding misperceptions and establishing realities: the need for reliable epidemiological data.
    Groft SC; de la Paz MP
    Adv Exp Med Biol; 2010; 686():3-14. PubMed ID: 20824436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hub and spoke model: making rural healthcare in India affordable, available and accessible.
    Devarakonda S
    Rural Remote Health; 2016; 16(1):3476. PubMed ID: 26836754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomics of rare genetic diseases-experiences from India.
    ; Sivasubbu S; Scaria V
    Hum Genomics; 2019 Sep; 14(1):52. PubMed ID: 31554517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of mission statements in Flemish not-for-profit healthcare organizations.
    Vandijck D; Desmidt S; Buelens M
    J Nurs Manag; 2007 Mar; 15(2):131-41. PubMed ID: 17352695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community service: starting a not-for-profit foundation.
    Ness JD; Glatte HA
    Med Group Manage J; 1998; 45(3):20-2. PubMed ID: 10181633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAD-AID International.
    Peart O; Everton K; Kobeski J
    Radiol Technol; 2014; 86(1):100-2. PubMed ID: 25224093
    [No Abstract]   [Full Text] [Related]  

  • 14. Principles for interactions with biopharmaceutical companies: the development of guidelines for patient advocacy organizations in the field of rare diseases.
    Stein S; Bogard E; Boice N; Fernandez V; Field T; Gilstrap A; Kahn SR; Larkindale J; Mathieson T
    Orphanet J Rare Dis; 2018 Jan; 13(1):18. PubMed ID: 29357903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing the role of nonprofit health care.
    Metcalfe M
    Inquiry; 2002; 39(2):96-100. PubMed ID: 12371573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serving women who use drugs in Delhi, India: challenges and achievements.
    Sarin E; Selhore E
    Int J Drug Policy; 2008 Apr; 19(2):176-8. PubMed ID: 18313911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Organization for Rare Disorders (NORD): providing advocacy for people with rare disorders.
    Putkowski S
    NASN Sch Nurse; 2010 Jan; 25(1):38-41. PubMed ID: 20440954
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of patient organizations in the rare disease ecosystem in India: an interview based study.
    Choudhury MC; Saberwal G
    Orphanet J Rare Dis; 2019 May; 14(1):117. PubMed ID: 31142331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings for the 5th Asia-Pacific Conference on Disaster Medicine: creating an agenda for action.
    De Grace M; Ericson D; Folz H; Greene W; Ho K; Pearce L
    Prehosp Disaster Med; 2001; 16(1):18-21. PubMed ID: 11367932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organizational resilience: Nonprofit organizations' response to change.
    Witmer H; Mellinger MS
    Work; 2016 May; 54(2):255-65. PubMed ID: 27232060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.